Key statistics
As of last trade Dyne Therapeutics Inc (DYN:NSQ) traded at 30.08, -36.62% below its 52-week high of 47.45, set on Aug 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.00 |
---|---|
High | 30.37 |
Low | 29.18 |
Bid | 30.03 |
Offer | 30.12 |
Previous close | 29.73 |
Average volume | 1.34m |
---|---|
Shares outstanding | 101.77m |
Free float | 100.56m |
P/E (TTM) | -- |
Market cap | 3.03bn USD |
EPS (TTM) | -3.56 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:22 GMT.
More ▼
Announcements
- Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Dyne Therapeutics to Present at Upcoming Investor Conferences
- Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases
- Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
- Dyne Therapeutics Announces Key Leadership Appointments
- Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts
- Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
- Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
- Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
More ▼